Share-based Payment Arrangement, Expense of MEDIFAST INC from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
MEDIFAST INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • MEDIFAST INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $910,000, a 50% increase year-over-year.
  • MEDIFAST INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $7,599,000, a 0.33% decline year-over-year.
  • MEDIFAST INC annual Share-based Payment Arrangement, Expense for 2024 was $7,363,000, a 10% decline from 2023.
  • MEDIFAST INC annual Share-based Payment Arrangement, Expense for 2023 was $8,188,000, a 26% decline from 2022.
  • MEDIFAST INC annual Share-based Payment Arrangement, Expense for 2022 was $11,053,000, a 12% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

MEDIFAST INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,599,000 $910,000 +$304,000 +50% 01 Jul 2025 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $7,295,000 $2,627,000 +$173,000 +7% 01 Apr 2025 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $7,122,000 $1,930,000 -$241,000 -11% 01 Jan 2025 31 Mar 2025 10-Q 28 Apr 2025 2025 Q1
Q4 2024 $7,363,000 $2,132,000 -$261,000 -11% 01 Oct 2024 31 Dec 2024 10-K 18 Feb 2025 2024 FY
Q3 2024 $7,624,000 $606,000 -$2,069,000 -77% 01 Jul 2024 30 Sep 2024 10-Q 03 Nov 2025 2025 Q3
Q2 2024 $9,693,000 $2,454,000 -$60,000 -2.4% 01 Apr 2024 30 Jun 2024 10-Q 04 Aug 2025 2025 Q2
Q1 2024 $9,753,000 $2,171,000 +$1,565,000 +258% 01 Jan 2024 31 Mar 2024 10-Q 28 Apr 2025 2025 Q1
Q4 2023 $8,188,000 $2,393,000 -$557,000 -19% 01 Oct 2023 31 Dec 2023 10-K 18 Feb 2025 2024 FY
Q3 2023 $8,745,000 $2,675,000 -$288,000 -9.7% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024 2024 Q3
Q2 2023 $9,033,000 $2,514,000 -$351,000 -12% 01 Apr 2023 30 Jun 2023 10-Q 05 Aug 2024 2024 Q2
Q1 2023 $9,384,000 $606,000 -$1,669,000 -73% 01 Jan 2023 31 Mar 2023 10-Q 29 Apr 2024 2024 Q1
Q4 2022 $11,053,000 $2,950,000 -$288,000 -8.9% 01 Oct 2022 31 Dec 2022 10-K 18 Feb 2025 2024 FY
Q3 2022 $11,341,000 $2,963,000 +$694,000 +31% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2023 Q3
Q2 2022 $10,647,000 $2,865,000 +$667,000 +30% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023 2023 Q2
Q1 2022 $9,980,000 $2,275,000 +$77,000 +3.5% 01 Jan 2022 31 Mar 2022 10-Q 01 May 2023 2023 Q1
Q4 2021 $9,903,000 $3,238,000 01 Oct 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
Q3 2021 $2,269,000 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $2,198,000 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $2,198,000 01 Jan 2021 31 Mar 2021 10-Q 02 May 2022 2022 Q1

MEDIFAST INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $7,363,000 -$825,000 -10% 01 Jan 2024 31 Dec 2024 10-K 18 Feb 2025 2024 FY
2023 $8,188,000 -$2,865,000 -26% 01 Jan 2023 31 Dec 2023 10-K 18 Feb 2025 2024 FY
2022 $11,053,000 +$1,150,000 +12% 01 Jan 2022 31 Dec 2022 10-K 18 Feb 2025 2024 FY
2021 $9,903,000 +$3,107,000 +46% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
2020 $6,796,000 +$2,276,000 +50% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023 2022 FY
2019 $4,520,000 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.